Drreddys Laboratories | RDY - Loan Capital


Drreddys Laboratories reported INR129.19M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
ANI Pharmaceuticals USD 291.84M 5.84M Dec/2025
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Canopy Growth CAD 224.99M 1.34M Dec/2025
Cipla INR 2.98B 454.6M Sep/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Pacira USD 372.19M 4.53M Dec/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Richter Gedeon HUF 15.14B 537M Dec/2025
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025